Aterian(US:ATER)2020-05-11 21:11Product Launch and Revenue Growth - Mohawk launched 16 new products in the first quarter of 2020, achieving a 47.7% growth in direct net revenue compared to the previous year[50]. - The company aims for a target average of positive 10% net margin for products within approximately three months of launch[49]. - Direct sales volume contributed an increase of $8.1 million, or 47.7%, primarily from growth in the existing product portfolio and new products released in the second half of 2019[67]. - Net revenue increased by $7.8 million, or 43.6%, to $25.6 million for the three months ended March 31, 2020, compared to $17.8 million for the same period in 2019[67]. Financial Performance Metrics - The contribution margin, which reflects operating loss plus general and administrative expenses, is a key metric for assessing product performance[54]. - Adjusted EBITDA was $(5.6) million for the three months ended March 31, 2020, compared to $(6.4) million for the same period in 2019, representing an improvement[61]. - Contribution margin as a percentage of net revenue was (2.9)% for the three months ended March 31, 2020, compared to (4.5)% for the same period in 2019[59]. - Operating loss increased by $6.8 million, or 94.8%, to $(13.9) million for the three months ended March 31, 2020, compared to $(7.1) million for the same period in 2019[63]. - Net loss was $(15.0) million for the three months ended March 31, 2020, compared to $(8.4) million for the same period in 2019, reflecting a 79.2% increase[63]. Cost and Expense Analysis - Gross profit rose by $3.6 million, or 54.4%, to $10.3 million for the three months ended March 31, 2020, compared to $6.7 million for the same period in 2019[69]. - Cost of goods sold increased by $4.2 million, or 37.2%, to $15.3 million during the three months ended March 31, 2020[70]. - Gross margin improved to 40.2% for the three months ended March 31, 2020, up from 37.4% for the same period in 2019[70]. - Research and development expenses increased by $1.1 million, or 96.1%, to $2.3 million for the three months ended March 31, 2020, compared to $1.2 million for the same period in 2019[63]. - Sales and distribution expenses increased by $4.6 million from $9.3 million for the three months ended March 31, 2019 to $13.9 million for the three months ended March 31, 2020, representing a 50.0% increase[71]. - General and administrative expenses increased by $4.6 million from $3.4 million for the three months ended March 31, 2019 to $8.0 million for the three months ended March 31, 2020[73]. Operational and Strategic Developments - Mohawk's products are currently in the launch and sustain phases, with none achieving the milk phase yet[49]. - The company has expanded its fulfillment capabilities by adding five fulfillment by Mohawk (FBM) warehouses, covering approximately 90% of the U.S.[53]. - The company added five third-party FBM warehouses to its direct fulfillment platform, enabling One Day Prime delivery for 90% of the United States[71]. - The key manufacturing partner in China reopened its facilities on February 10, 2020, and reached over 90% capacity by early March 2020, expected to manufacture over 30% of the company's inventory in 2020[82]. Risks and Uncertainties - The company is exposed to tariff risks due to reliance on manufacturers in China, which could impact cost of goods sold[51]. - The future impact of the COVID-19 pandemic on personnel, business operations, and financial condition remains uncertain, with potential disruptions across the value chain[82]. - The company may experience a substantial decrease in demand for its products, most of which are considered non-essential, during the pandemic[82]. - The company intends to seek additional financing options, which may be expensive and/or dilutive, due to uncertainty regarding compliance with existing loan agreements[82]. - The company is currently seeking to preserve liquidity through various actions, including delaying payments to certain vendors, which may adversely impact business relationships[82]. Cash Flow and Financing - Cash used in operating activities increased from $11.9 million for the three months ended March 31, 2019 to $17.1 million for the three months ended March 31, 2020[76]. - Net cash provided by financing activities decreased from $4.6 million for the three months ended March 31, 2019 to $0.8 million for the three months ended March 31, 2020[78]. - The accumulated deficit increased from $129.8 million at December 31, 2019 to $144.8 million at March 31, 2020[79]. - Cash on hand decreased from $30.4 million at December 31, 2019 to $14.1 million at March 31, 2020[79]. - As of March 31, 2020, the outstanding indebtedness under the Credit Facility was $25.0 million, bearing interest at LIBOR plus 5.75%, and the Term Loan was $15.0 million, bearing interest at 9.90% plus a variable rate[85]. Currency and Interest Rate Exposure - Sales outside of the United States represented less than 1% of net revenue for the three months ended March 31, 2019, and 2020, indicating minimal foreign currency exposure[85]. - The company does not currently engage in hedging transactions to manage foreign currency exchange rate risk, as exposure is considered minimal[85]. - An immediate 100 basis point change in interest rates would not materially affect the fair market value of the company's investments due to their short-term maturities and low risk profiles[85]. - Interest expense, net decreased by $0.1 million from $1.2 million for the three months ended March 31, 2019 to $1.1 million for the three months ended March 31, 2020, an 8.5% decrease[74]. - Inflation has not had a material effect on the company's business, financial condition, or results of operations for the three months ended March 31, 2019, and 2020[85].